# OncoInsight

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oncoinsight

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.oncoinsight.co.kr
- Total disclosed funding: $21M
- Latest round: Series A (Jul 26, 2021)
- Investors on record: 8

## About

Based in Seoul, South Korea and founded in 2017, OncoInsight develops and delivers NK cell therapy product candidates to cancer patients while building a platform developing immune cell therapy based on One-stop CAR (chimeric antigen receptor). CAR NK call therapy involves infusion of NK cells that have been genetically engineered to express a chimeric antigen receptor (CAR) to reprogram the NK cells. The company has secured mass production technology for anticancer immune cell therapy through its proprietary hematopoietic stem cell-derived NK cell differentiation and culture technology. In addition, based on the CAR-NK cell therapy development platform that introduced CAR specific to cancer cell antigen, it has a total of three anticancer immune cell therapy pipelines, including gastric cancer and triple-negative breast cancer target pipelines.

The company's main pipeline OI-101, is a cancer-targeted immune cell therapy, which is currently developing lung cancer as its main indication and anticancer immune cell therapy pipelines, including CAR-NK cell therapies OI-201 and OI-203 for gastric cancer and triple-negative breast cancer.

## Funding rounds

- Series A, Jul 26, 2021, $19M — SBI Investment Korea, Korea Investment Partners, WONIK Investment Partners, Kiwoom Investment, KB Securities, Nvestor, BSK Investment, Rico Asset Management
- Seed, Feb 4, 2020, $2.5M — Korea Investment Partners, Kiwoom Investment, BSK Investment

## Investors

- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Seed, Series A
- Kiwoom Investment (https://capitalatlas.ai/funds/kiwoom-investment) — Seed, Series A
- BSK Investment (https://capitalatlas.ai/funds/bsk-investment) — Seed, Series A
- SBI Investment Korea (https://capitalatlas.ai/funds/sbi-investment-korea) — Series A
- WONIK Investment Partners (https://capitalatlas.ai/funds/wonik-investment-partners) — Series A
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series A
- Nvestor (https://capitalatlas.ai/funds/nvestor) — Series A
- Rico Asset Management — Series A